top
Search terms
Results 1 - 8 of 8 - ordered by :
Escardio

To answer these questions, 12 obese patients (7 men, mean age 48.3 ± 2.3 yrs) with insulin treated type 2 diabetes mellitus (T2DM) were put on a very-lowcalorie diet (VLCD; 450 kcal/day) for a ...

Date : 30/11/2008
Escardio

Diabetes mellitus chronically impairs the passive extensibility of the heart muscle cells [2-4]. Clinically, increased left ventricular cardiac stiffness is considered the earliest manifestation of ...

Date : 10/12/2018
Escardio

European Heart Journal - Cardiovascular Pharmacotherapy, Volume 5, Issue 2, April 2019, Pages 70–79 Dr Camm et al. analysed XANTUS study data and assessed outcomes associated with ...

Date : 01/04/2019
Escardio

The Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial (REDUCE-IT) already published and presented during AHA 20181 randomized 8179 patients with established ...

Date : 06/05/2019
Escardio

Watch the webinar recording Faculty Speakers Professor Giuseppe Rosano, FESC, FHFA St George's Hospital Medical School London, United Kingdom Professor Petar Seferovic, FESC, FHFA Belgrade University ...

Date : 01/03/2019
Escardio

The success of neurohormonal and heart rate control Prof. Luigi Tavazzi (Cotignola, IT) New scenarios in medical science Heart Failure 2015 Lecture Prof. Eugene Braunwald (Boston, US) - First ...

Date : 18/09/2018
Escardio

Prof. Ivan Tomov Gruev, Chairman of the working group on epidemiology, prevention and rehabilitation of CVD of the Bulgarian Society of Cardiology National CVD Prevention Coordinator for Bulgaria: ...

Date : 04/06/2014
Escardio

Atherosclerotic cardiovascular disease ? ASCVD-, either clinical or unequivocal on imaging (CT scan included in these guidelines); diabetes mellitus with target organ damage, long standing duration ...

Date : 31/10/2019